Premium
Different β‐adrenoceptor subtypes coupling to cAMP or NO / cGMP pathways: implications in the relaxant response of rat conductance and resistance vessels
Author(s) -
Flacco N,
Segura V,
PerezAso M,
Estrada S,
Seller JF,
JiménezAltayó F,
Noguera MA,
D'Ocon P,
Vila E,
Ivorra MD
Publication year - 2013
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/bph.12121
Subject(s) - adenylyl cyclase , soluble guanylyl cyclase , vasodilation , electrical impedance myography , isoprenaline , endothelium , endocrinology , medicine , propranolol , forskolin , chemistry , biology , pharmacology , nitric oxide , receptor , stimulation , guanylate cyclase
Background and Purpose To analyse the relative contribution of β 1 ‐, β 2 ‐ and β 3 ‐adrenoceptors ( Adrb ) to vasodilatation in conductance and resistance vessels, assessing the role of cAMP and/or NO / cGMP signalling pathways. Experimental Approach Rat mesenteric resistance artery ( MRA ) and aorta were used to analyse the Adrb expression by real‐time ‐PCR and immunohistochemistry, and for the pharmacological characterization of Adrb ‐mediated activity by wire myography and tissue nucleotide accumulation. Key Results The mRNAs and protein for all Adrb were identified in endothelium and/or smooth muscle cells ( SMCs ) in both vessels. In MRA , Adrb1 signalled through cAMP , Adrb3 through both cAMP and cGMP , but Adrb2 , did not activate nucleotide formation; isoprenaline relaxation was inhibited by propranolol (β 1 , β 2 ), CGP20712A (β 1 ), and SQ22536 (adenylyl cyclase inhibitor), but not by ICI118 ,551 (β 2 ), SR59230A (β 3 ), ODQ (soluble guanylyl cyclase inhibitor), L‐ NAME or endothelium removal. In aorta, Adrb1 signalled through cAMP , while β 2 ‐ and β 3 ‐subtypes through cGMP ; isoprenaline relaxation was inhibited by propranolol, ICI118 ,551, ODQ , L ‐ NAME , and to a lesser extent, by endothelium removal. CL316243 (β 3 ‐agonist) relaxed aorta, but not MRA . Conclusion and Implication Despite all three Adrb subtypes being found in both vessels, Adrb1 , located in SMCs and acting through the adenylyl cyclase/ cAMP pathway, are primarily responsible for vasodilatation in MRA . However, Adrb ‐mediated vasodilatation in aorta is driven by endothelial Adrb2 and Adrb3 , but also by the Adrb2 present in SMCs , and is coupled to the NO / cGMP pathway. These results could help to understand the different physiological roles played by Adrb signalling in regulating conductance and resistance vessels.